- Willow Biosciences Inc at Emerging Growth Conference TranscriptAug 09, 2023
- Willow Biosciences Inc at Emerging Growth Conference TranscriptJun 14, 2023
- Willow Biosciences Inc at SRAX Sequire Biotechnology Conference (Virtual) TranscriptFeb 02, 2023
- Willow Biosciences Inc Investor Presentation TranscriptNov 10, 2022
Willow Biosciences Inc at Emerging Growth Conference Transcript
Welcome back, everyone. Next up, we have Willow Biosciences. It trades on the OTCQB under the symbol CANSF and on the TSX under the symbol WLLW and is a leading biotech company that develops precision fermentation processes for sustainable and cost-effective production of natural functional ingredients used in consumer care, food and beverage, and pharmaceutical products. Using their future-grown engineering platform, they can rapidly develop bio-based industrial processes to replace unsustainable, higher-cost extracted, and synthetic ingredients.
Today, we have with us Willow's CEO, Chris Savile. Now, Willow Biosciences' CEO has close to 20 years' experience in science, commercial, and operations roles in biotech. He is a highly experienced scientific and business leader, focused on the scale up and commercialization of bio-based processes for specialty chemicals, food and beverage, and pharma. Dr. Savile has acted as a technical and commercial leader on several large R&D programs that led to commercial processes. Prior to Willow, Dr. Savile worked at
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)